Portfolio item number 2
Short description of portfolio item number 2 
Short description of portfolio item number 2 
Published in BIBM 2024 DLB2H Workshop, 2024
In this paper, a deep neural network based model is proposed to predict protein methylation, which is called by DeepMethy.
Recommended citation: Songye Gao†, Cheng Xin†, Sisi Ou, Jinru Li, Yanchun Liang and Xiaohu Shi*(2024). "Paper Title Number 1." DeepMethy: A deep learning model for protein methylation site prediction. BIBM 2024 DLB2H Workshop.
Download Paper
Published in bioRxiv, 2024
Clair3-RNA is a deep learning-based variant caller designed for small variant detection in long-read RNA-seq data. It improves both accuracy and speed by combining signal-level features, splicing-aware alignment, and attention-based neural network architectures. This tool enables high-throughput variant discovery from transcriptomic data in research and clinical applications.
Recommended citation: Zhenxian Zheng, Xian Yu, Lei Chen, Yan-Lam Lee, Cheng Xin, et al.(2024). Clair3-RNA: A deep learning-based small variant caller for long-read RNA sequencing data. bioRxiv.
Download Paper
Published in NeurIPS 2025 Conference Submission, 2025
LVstyler, an innovative generative framework that extends beyond the conventional 0-to-1 UV texture synthesis, specializing in a more varied style transfer for 3D meshes while preserving geometric fidelity.
Recommended citation: Hokit Fung, chengyangdong, Cheng Xin, Jie Li, Adela S.M. Lau, Guosheng Yin*(2025).LVstyler: LoRa-enhanced Varied High-Quality Texture Generation with Text Alignment. NeurIPS 2025 Conference Submission
Published in Journal 1, 2025
This paper systematically reviews recent advances in artificial intelligence (AI), with a particular focus on machine learning (ML), across the entire drug discovery pipeline.
Recommended citation: Junwei Su†, Cheng Xin†, Ao Shang, Shan Wu, Zhenzhen Xie, Ruogu Xiong, Xiaoyu Xu, Cheng Zhang, Guang Chen, Yau-Tuen Chan, Guoyi Tang*, Ning Wang, Yong Xu, Yibin Feng*(2025). Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy. Submit to Acta Pharmaceutica Sinica B.
Published:
This is a description of your talk, which is a markdown file that can be all markdown-ified like any other post. Yay markdown!
Published:
This is a description of your conference proceedings talk, note the different field in type. You can put anything in this field.
Undergraduate course, University 1, Department, 2014
This is a description of a teaching experience. You can use markdown like any other post.
Workshop, University 1, Department, 2015
This is a description of a teaching experience. You can use markdown like any other post.